Published in J Appl Physiol Respir Environ Exerc Physiol on September 01, 1980
Dynamic laryngeal narrowing during exercise: a mechanism for generating intrinsic PEEP in COPD? Thorax (2015) 2.00
Vocal cord dysfunction and wheezing. Thorax (1991) 1.82
Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax (1987) 1.77
Bronchial responsiveness to histamine in wheezy infants. Thorax (1987) 1.17
Comparison of in vivo airway responsiveness and in vitro smooth muscle sensitivity to methacholine in man. Thorax (1984) 1.11
Laryngeal resistance immediately after panting in asthmatic subjects. Thorax (1989) 0.75
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med (1996) 11.76
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
Caution with use of inhaled nitric oxide. Lancet (1996) 3.87
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet (2000) 2.82
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
Angiotensin-converting enzyme and the cough reflex. Lancet (1987) 1.94
Bronchial disease in ulcerative colitis. Thorax (1980) 1.72
Heart-lung transplantation for cystic fibrosis. Lancet (1988) 1.70
Cigarettes, lung cancer, and coronary heart disease: the effects of inhalation and tar yield. J Epidemiol Community Health (1982) 1.68
Safety guidelines for use of nitric oxide. Lancet (1992) 1.62
The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest (1990) 1.60
Nicotine concentrations in urine and saliva of smokers and non-smokers. Br Med J (Clin Res Ed) (1982) 1.59
Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet (1984) 1.59
Plasma concentrations of lignocaine during fibreoptic bronchoscopy. Thorax (1982) 1.52
Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Lancet (1980) 1.50
High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respir Med (1992) 1.48
Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant (1993) 1.47
Heart and lung transplantation in patients with end stage lung disease. Br Med J (Clin Res Ed) (1987) 1.37
Measurement of exhaled nitric oxide in man. Thorax (1993) 1.35
Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet (1994) 1.22
Carbon monoxide yield of cigarettes and its relation to cardiorespiratory disease. Br Med J (Clin Res Ed) (1983) 1.16
Selection and procurement of combined heart and lung grafts for transplantation. J Thorac Cardiovasc Surg (1988) 1.14
Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis (1989) 1.11
International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant (1998) 1.08
Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J (2005) 1.08
Exhaled nitric oxide in isolated pig lungs. J Appl Physiol (1985) (1995) 1.07
Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant (1994) 1.06
Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man. J Physiol (1994) 1.05
The importance of cytomegalovirus in heart-lung transplant recipients. Chest (1989) 1.04
Heart-lung transplantation: better use of resources. Am J Med (1988) 1.02
UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intensive Care Med (1997) 1.01
Inhibition of artificially induced cough in man by bronchodilators. Br J Clin Pharmacol (1987) 1.00
Successful heart-lung transplantation for cystic fibrosis. Chest (1988) 0.99
Glottis narrowing in lung disease. Am Rev Respir Dis (1982) 0.99
Absence of electrochemical defect of cystic fibrosis in transplanted lung. Lancet (1987) 0.98
Lung function associated with histologically diagnosed acute lung rejection and pulmonary infection in heart-lung transplant patients. Am Rev Respir Dis (1990) 0.98
Antitussive properties of inhaled bronchodilators on induced cough. Chest (1988) 0.96
The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level. Eur Respir J (2008) 0.95
New therapies for primary pulmonary hypertension. Chest (1994) 0.93
Cough associated with angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol (1989) 0.93
The role of thrombosis in severe pulmonary hypertension. Eur Respir J (1996) 0.93
Cystic fibrosis. 5. The current state of lung transplantation for cystic fibrosis. Thorax (1991) 0.92
A method for standardizing airway resistance for variations in lung volume. Clin Sci (Lond) (1979) 0.92
Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am Rev Respir Dis (1993) 0.91
International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation (1998) 0.91
Abdominal wall movement in normals and patients with hemidiaphragmatic and bilateral diaphragmatic palsy. Thorax (1977) 0.91
Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity. QJM (1994) 0.90
Variable intrathoracic airways obstruction masquerading as asthma. Br Med J (Clin Res Ed) (1983) 0.89
Heart and lung transplantation for terminal cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg (1991) 0.88
Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant (1992) 0.88
The role of physiological deadspace and shunt in the gas exchange of patients with pulmonary hypertension: a study of exercise and prostacyclin infusion. Eur Respir J (1988) 0.88
Pulmonary epithelial permeability after inhaling saline, distilled water "fog" and cold air. Chest (1985) 0.88
The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension. Br J Clin Pract (1990) 0.86
Acute renal failure from the use of acetazolamide (Diamox). Postgrad Med J (1978) 0.86
Lung Transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital. J Heart Lung Transplant (1996) 0.86
The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections. Br J Clin Pharmacol (1994) 0.86
Giving up smoking. Thorax (1984) 0.85
Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension. Chest (1989) 0.84
Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest (2001) 0.83
A comparison of exercise, hyperventilation with cold air and warm air, and the inhalation of "fog" in the provocation of asthma. Eur J Respir Dis Suppl (1983) 0.82
Nitric oxide yields of contemporary UK, US and French cigarettes. Int J Epidemiol (1987) 0.82
Reduction of pulmonary capillary blood volume in patients with severe unexplained pulmonary hypertension. Thorax (1996) 0.82
Low dose infusion of atrial natriuretic peptide causes salt and water excretion in normal man. Clin Sci (Lond) (1988) 0.82
Cough induced by changes of ionic composition of airway surface liquid. Bull Eur Physiopathol Respir (1985) 0.82
Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned? Am J Respir Crit Care Med (1997) 0.81
Primary pulmonary hypertension. Br Med J (Clin Res Ed) (1986) 0.81
The place of prostacyclin in the clinical management of primary pulmonary hypertension. Am Rev Respir Dis (1987) 0.81
Distant procurement of organs for clinical heart-lung transplantation using a single flush technique. Transplantation (1987) 0.81
Early graft function following heart and lung transplantation. Transpl Int (1989) 0.80
Transplantation of the lungs and heart and lung for patients with severe pulmonary complications from sarcoidosis. Sarcoidosis (1990) 0.80
Pulmonary reflexes after human heart-lung transplantation. Respir Med (1991) 0.80
The effect of recipient lung size on lung physiology after heart-lung transplantation. Transplantation (1989) 0.80
Bronchial reactivity in asthmatic adults with normal spirometric values. Br Med J (Clin Res Ed) (1983) 0.79
Further clinical observations on the pulmonary effects of paraquat ingestion. Thorax (1979) 0.79
Transplantation for end-stage lung disease. Respiration (1991) 0.79
Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy. J Heart Transplant (1989) 0.79
Practical importance of a preceding full inhalation or exhalation upon the measurement of airway resistance. Clin Sci (Lond) (1980) 0.78
Influence of breath holding at total lung capacity on maximal expiratory flow measurements. Clin Sci (Lond) (1981) 0.78
Successful use of repeated transbronchial lung biopsies in a patient with multiple opportunistic infections. Respir Med (1989) 0.78
Acute effects of smoking a single cigarette on the airway resistance and the maximal and partial forced expiratory flow volume curves. Br J Dis Chest (1980) 0.78
Nature and site of action of endogenous nitric oxide in vasculature of isolated pig lungs. J Appl Physiol (1985) (1997) 0.77
Cigarette smoke inhalation and the acute airway response. Thorax (1980) 0.77
Inhaled nitric oxide: a magic bullet? Q J Med (1993) 0.77
Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome. Respiration (2001) 0.76
Pulmonary hypertension, family and environment. J Hum Hypertens (1997) 0.75
Nitric oxide and exercise in the horse. J Physiol (1996) 0.75
Single lung transplantation and pulmonary hypertension. Br Heart J (1992) 0.75
Intravenous epoprostenol for primary pulmonary hypertension. N Engl J Med (1996) 0.75
Airway complications after lung transplantation: is there a left-sided predilection? J Thorac Cardiovasc Surg (1995) 0.75
Smoking in patients with advanced lung disease. Br Med J (Clin Res Ed) (1983) 0.75
Transbronchial biopsy after lung transplantation. J Thorac Cardiovasc Surg (1991) 0.75
Pulmonary hypertension. Br Med J (Clin Res Ed) (1987) 0.75
Lung transplantation and asthma. Lancet (1993) 0.75
Chondritis associated with fatal intramural bronchial fibrosis. Thorax (1979) 0.75
International Primary Pulmonary Hypertension Study. Br Heart J (1994) 0.75
Proteins of the respiratory tract after heart-lung transplantation. Transplantation (1990) 0.75
Highlights on pulmonary hypertension: a commentary. Eur Respir J (1993) 0.75
Single lung transplantation for end stage emphysema. Thorax (1995) 0.75
The influence of controlled release theophylline on cold air induced bronchoconstriction in asthma. Br J Clin Pract Suppl (1984) 0.75